Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 352,800,000
  • Market Capitalization, $K 352,800
  • Shares Outstanding, K 2,400
  • 60-Month Beta 1.09
  • Price/Earnings ttm 25.08
  • Annual Dividend & Yield 1.79 (1.21%)
  • Most Recent Dividend 0.557 on 03/20/19
  • Management Fee 0.43%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
143.12 +3.48%
on 04/18/19
155.15 -4.54%
on 04/05/19
-3.72 (-2.45%)
since 03/25/19
3-Month
142.40 +4.01%
on 01/29/19
158.56 -6.59%
on 03/04/19
+3.29 (+2.27%)
since 01/25/19
52-Week
131.91 +12.28%
on 12/24/18
170.26 -13.01%
on 09/21/18
+3.00 (+2.07%)
since 04/25/18

Most Recent Stories

More News
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 88.35 (+0.25%)
VHT : 166.66 (+0.44%)
IHE : 148.39 (+0.20%)
IYH : 185.99 (+1.09%)
IEIH : 24.91 (+1.03%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 88.35 (+0.25%)
VHT : 166.66 (+0.44%)
IHE : 148.39 (+0.20%)
IYH : 185.99 (+1.09%)
IEIH : 24.91 (+1.03%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

TGTX : 8.07 (-0.25%)
RKDA : 6.35 (-1.85%)
XPH : 39.94 (+0.60%)
HZNP : 25.28 (-0.08%)
IHE : 148.39 (+0.20%)
PJP : 62.57 (+0.82%)
FTXH : 20.70 (+0.33%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

TGTX : 8.07 (-0.25%)
RKDA : 6.35 (-1.85%)
XPH : 39.94 (+0.60%)
HZNP : 25.28 (-0.08%)
IHE : 148.39 (+0.20%)
PJP : 62.57 (+0.82%)
FTXH : 20.70 (+0.33%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

XPH : 39.94 (+0.60%)
IHE : 148.39 (+0.20%)
PJP : 62.57 (+0.82%)
PPH : 58.09 (+0.69%)
FTXH : 20.70 (+0.33%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

XPH : 39.94 (+0.60%)
IHE : 148.39 (+0.20%)
PJP : 62.57 (+0.82%)
PPH : 58.09 (+0.69%)
FTXH : 20.70 (+0.33%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

NVO : 48.81 (+0.78%)
PJP : 62.57 (+0.82%)
IHE : 148.39 (+0.20%)
LLY : 119.26 (+0.87%)
PPH : 58.09 (+0.69%)
GSK : 40.24 (+0.05%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

XLV : 88.35 (+0.25%)
VHT : 166.66 (+0.44%)
JNJ : 139.89 (+0.17%)
IHE : 148.39 (+0.20%)
IYH : 185.99 (+1.09%)
IEIH : 24.91 (+1.03%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

XLV : 88.35 (+0.25%)
VHT : 166.66 (+0.44%)
JNJ : 139.89 (+0.17%)
IHE : 148.39 (+0.20%)
IYH : 185.99 (+1.09%)
IEIH : 24.91 (+1.03%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

AZN : 37.81 (-3.20%)
MRK : 76.63 (+0.38%)
PJP : 62.57 (+0.82%)
IHE : 148.39 (+0.20%)
PPH : 58.09 (+0.69%)
PFE : 39.74 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade IHE with:

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

2nd Resistance Point 149.36
1st Resistance Point 148.73
Last Price 148.39
1st Support Level 146.85
2nd Support Level 145.59

See More

52-Week High 170.26
Fibonacci 61.8% 155.61
Fibonacci 50% 151.08
Last Price 148.39
Fibonacci 38.2% 146.56
52-Week Low 131.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar